These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1719687)

  • 1. [Ureteral stents].
    Chaussy C; von Wallenberg Pachaly H
    Urologe A; 1991 Sep; 30(5):282-4. PubMed ID: 1719687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of malignant ureteral obstruction treated with ureteral stents.
    Ganatra AM; Loughlin KR
    J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indications and methods of invasive minimal urinary derivations in oncology].
    Praz V; Chollet Y; Jichlinski P
    Rev Med Suisse; 2007 Dec; 3(136):2788-90, 2792. PubMed ID: 18183814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of double "J" ureteral stents in cancerology].
    Dauplat J; Issert B; de Jolinière JB; Dal Soglio I; Giraud B
    Ann Urol (Paris); 1985; 19(4):233-8. PubMed ID: 2411207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
    Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
    Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stent-change therapy in advanced malignancies with ureteral obstruction.
    Rosenberg BH; Bianco FJ; Wood DP; Triest JA
    J Endourol; 2005; 19(1):63-7. PubMed ID: 15735386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal stents: a new treatment of malignant ureteral obstruction.
    Barbalias GA; Siablis D; Liatsikos EN; Karnabatidis D; Yarmenitis S; Bouropoulos K; Dimopoulos J
    J Urol; 1997 Jul; 158(1):54-8. PubMed ID: 9186322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes.
    Kouba E; Wallen EM; Pruthi RS
    J Urol; 2008 Aug; 180(2):444-50. PubMed ID: 18550089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ureteral obstruction and stents: still a difficult problem for patients and urologists alike.
    Russo P
    J Urol; 2005 Dec; 174(6):2088. PubMed ID: 16280733
    [No Abstract]   [Full Text] [Related]  

  • 11. Endourologic treatments of distal ureteral obstruction in patients with history of pelvic malignancies: efficacy and safety evaluation.
    Wen XQ; Gao X; Zhang Y; Cai YB; Qiu JG; Situ J; Zhan HL; Wang DJ
    Ai Zheng; 2007 Nov; 26(11):1227-30. PubMed ID: 17991323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
    Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
    J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Authors reply.
    Wijayarathna S; Suvendran S; Ishak M; Weligamage A; Epa A; Munasinghe S; Abeygunasekera AM
    Ceylon Med J; 2015 Jun; 60(2):76. PubMed ID: 26349085
    [No Abstract]   [Full Text] [Related]  

  • 14. Outcome analysis and cost comparison between externalized pyeloureteral and standard stents in 470 consecutive open pyeloplasties.
    Braga LH; Lorenzo AJ; Farhat WA; Bägli DJ; Khoury AE; Pippi Salle JL
    J Urol; 2008 Oct; 180(4 Suppl):1693-8; discussion1698-9. PubMed ID: 18708220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wall stents for treatment of malignant ureteral obstruction].
    Lugmayr H; Pauer W
    Aktuelle Radiol; 1994 May; 4(3):146-8. PubMed ID: 7519450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan.
    Rosevear HM; Kim SP; Wenzler DL; Faerber GJ; Roberts WW; Wolf JS
    Urology; 2007 Nov; 70(5):846-50. PubMed ID: 18068437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technique for Resonance® stent exchange in patients with extrinsic obstruction: description of a novel approach and literature review.
    Potretzke AM; Chang H; Kryger JV
    J Pediatr Urol; 2012 Oct; 8(5):557-9. PubMed ID: 22370061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Outcome of retrograde ureteric stenting as a urinary drainage procedure in ureteric obstruction related to malignant lesions.
    Goonewardena SA; Vickneswaran K
    Ceylon Med J; 2015 Jun; 60(2):75-6. PubMed ID: 26132194
    [No Abstract]   [Full Text] [Related]  

  • 19. Endourologic management of severely encrusted ureteral stents.
    Lojanapiwat B
    J Med Assoc Thai; 2005 Sep; 88(9):1203-6. PubMed ID: 16536105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy palliation in malignancy-associated ureteral obstruction.
    Ampil FL
    Radiat Med; 1989; 7(6):282-6. PubMed ID: 2483756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.